*Development of recombinant proteins and thir implementation into diagnostic kits.
Public support
Provider
Ministry of Industry and Trade
Programme
IMPULSE
Call for proposals
IMPULS 3 (SMPO200600003)
Main participants
—
Contest type
VS - Public tender
Contract ID
FI-IM3/134
Alternative language
Project name in Czech
*Vývoj rekombinantních proteinů a jejich implementace do diagnostických souprav.
Annotation in Czech
*Aplikovat techniky molekulárního klonování pro syntézu a purifikaci biologicky aktivních proteinů, které jsou nutné pro sestavení diagnostických souprav a které mají stejné biologické vlastnosti jako nativní proteiny.
Scientific branches
R&D category
VV - Exeperimental development
CEP classification - main branch
EI - Biotechnology and bionics
CEP - secondary branch
EB - Genetics and molecular biology
CEP - another secondary branch
—
OECD FORD - equivalent branches <br>(according to the <a href="http://www.vyzkum.cz/storage/att/E6EF7938F0E854BAE520AC119FB22E8D/Prevodnik_oboru_Frascati.pdf">converter</a>)
10603 - Genetics and heredity (medical genetics to be 3)<br>10604 - Reproductive biology (medical aspects to be 3)<br>10605 - Developmental biology<br>10608 - Biochemistry and molecular biology<br>10609 - Biochemical research methods<br>20801 - Environmental biotechnology<br>20802 - Bioremediation, diagnostic biotechnologies (DNA chips and biosensing devices) in environmental management<br>20803 - Environmental biotechnology related ethics<br>20901 - Industrial biotechnology<br>20902 - Bioprocessing technologies (industrial processes relying on biological agents to drive the process) biocatalysis, fermentation<br>20903 - Bioproducts (products that are manufactured using biological material as feedstock) biomaterials, bioplastics, biofuels, bioderived bulk and fine chemicals, bio-derived novel materials<br>30101 - Human genetics<br>30401 - Health-related biotechnology<br>30402 - Technologies involving the manipulation of cells, tissues, organs or the whole organism (assisted reproduction)<br>30403 - Technologies involving identifying the functioning of DNA, proteins and enzymes and how they influence the onset of disease and maintenance of well-being (gene-based diagnostics and therapeutic interventions [pharmacogenomics, gene-based therapeutics])<br>30404 - Biomaterials (as related to medical implants, devices, sensors)<br>30405 - Medical biotechnology related ethics<br>40401 - Agricultural biotechnology and food biotechnology<br>40402 - GM technology (crops and livestock), livestock cloning, marker assisted selection, diagnostics (DNA chips and biosensing devices for the early/accurate detection of diseases) biomass feedstock production technologies, biopharming<br>40403 - Agricultural biotechnology related ethics
Completed project evaluation
Provider evaluation
V - Vynikající výsledky projektu (s mezinárodním významem atd.)
Project results evaluation
Recombinant human neuron-specific enolase (VSE), sex-hormone binding globulin (SHBG), cartillage oligometric matrix protein (COMP) and immunoreactive trypsine (IRT) were prepared. NSE and SHBG were implemented into immunodiagnostic assays.
Solution timeline
Realization period - beginning
Jun 17, 2006
Realization period - end
Dec 31, 2008
Project status
U - Finished project
Latest support payment
May 23, 2008
Data delivery to CEP
Confidentiality
C - Předmět řešení projektu podléhá obchodnímu tajemství (§ 504 Občanského zákoníku), ale název projektu, cíle projektu a u ukončeného nebo zastaveného projektu zhodnocení výsledku řešení projektu (údaje P03, P04, P15, P19, P29, PN8) dodané do CEP, jsou upraveny tak, aby byly zveřejnitelné.
Data delivery code
CEP09-MPO-FI-U/05:5
Data delivery date
Apr 19, 2011
Finance
Total approved costs
18,367 thou. CZK
Public financial support
6,868 thou. CZK
Other public sources
0 thou. CZK
Non public and foreign sources
11,499 thou. CZK